Phospholipid composition controls thromboplastin sensitivity to individual clotting factors.
about
Laboratory assessment of rivaroxaban: a review.Aortic thrombosis in dogs.Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?Harmonizing the International Normalized Ratio (INR) : Standardization of Methods and Use of Novel Strategies to Reduce Interlaboratory Variation and Bias.Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue-extract thromboplastins.Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
P2860
Phospholipid composition controls thromboplastin sensitivity to individual clotting factors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Phospholipid composition contr ...... o individual clotting factors.
@en
Phospholipid composition contr ...... o individual clotting factors.
@nl
type
label
Phospholipid composition contr ...... o individual clotting factors.
@en
Phospholipid composition contr ...... o individual clotting factors.
@nl
prefLabel
Phospholipid composition contr ...... o individual clotting factors.
@en
Phospholipid composition contr ...... o individual clotting factors.
@nl
P2860
P1476
Phospholipid composition contr ...... to individual clotting factors
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2006.01848.X
P577
2006-04-01T00:00:00Z